Viewing Study NCT02895490



Ignite Creation Date: 2024-05-06 @ 9:03 AM
Last Modification Date: 2024-10-26 @ 12:09 PM
Study NCT ID: NCT02895490
Status: TERMINATED
Last Update Posted: 2016-09-20
First Post: 2016-09-06

Brief Title: Communication Training in Promoting Employment Retention Among Cancer Patients
Sponsor: Virginia Commonwealth University
Organization: Virginia Commonwealth University

Study Overview

Official Title: Using Communication Training to Promote Employment Retention Among Cancer Survivors
Status: TERMINATED
Status Verified Date: 2016-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Grant endedfunding unavailable
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This randomized clinical trial studies communication training in promoting employment retention among cancer patients Communication training may improve patient-employer communication and increase the likelihood that cancer patients will remain employed reduce patients time away from work and increase workplace accommodations that enable patients to balance treatment and work
Detailed Description: PRIMARY OBJECTIVES

I Demonstrate the efficacy of the DVD intervention to a increase patients knowledge of their legal rights in the workplace b improve patient perceptions of workplace communication about the impact of cancer treatment and ongoing surveillance and c increase the number of requested and received workplace accommodations

II Compare employment status employed vs non-employed between the treatment and control arms

III Compare weekly hours of work between the treatment and control arms

OUTLINE Patients are randomized to 1 of 2 arms

Arm I Patients receive a DVD containing educational information about patients legal rights in the workplace and communication skills demonstrated through four scenarios depicting a variety of employer-employee communication challenges for patients provided by the Legal Information Network for Cancer LINC group

Arm II Patients receive information about the LINC group

After completion of study patients are followed up at 4 12 and 52 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2013-02478 REGISTRY None None
HM14021 OTHER None None
MCC-14021 OTHER Virginia Commonwealth UniversityMassey Cancer Center None